Risks and benefits of phase 1 clinical trials evaluating new anticancer agents: a case for more innovation.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/BCB99D2C.svg?ark=w1%2F20260515%2FBCB99D2C)](https://nobleid.org/work/w1/20260515/BCB99D2C)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors